CA SB958

Prohibits health care service plans and health insurers from requiring vendors to dispense infused or injected medications directly to patients for transport to health care providers ("brown-bagging").

Allows plans and insurers to arrange home administration of infused or injected medications only when the treating health care provider and patient jointly determine it is in the patient's best interest, with documentation required in the medical record.

Permits plans and insurers to require medications be supplied by a specified vendor only when strict criteria are met, including that the medication cannot be compounded at the administration site, does not contain controlled substances, does not require FDA risk evaluation and mitigation strategies, and the vendor can deliver within required timeframes with proper cold chain logistics.

Requires plans and insurers to implement a patient-specific exception process allowing providers to request alternative vendors based on safety or clinical appropriateness concerns, with review completed within 7 calendar days (or 24 hours for hospital discharge delays).

Prohibits plans and insurers from interfering with patients' rights to obtain covered medications from participating providers of their choice or basing coverage decisions on the site of service (physician's office, clinic, infusion center, or hospital outpatient department).